当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 现金流量表

人福医药

(600079)

  

流通市值:287.65亿  总市值:304.25亿
流通股本:15.43亿   总股本:16.32亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金17,060,278,711.3111,344,947,942.835,303,884,585.0324,143,262,438.27
  收到的税费返还171,267,139.6358,573,906.5326,430,476.8195,326,630.17
  收到其他与经营活动有关的现金314,524,238.59228,831,022.04117,301,969.89458,703,965.73
  经营活动现金流入小计17,546,070,089.5311,632,352,871.45,447,617,031.7324,697,293,034.17
  购买商品、接受劳务支付的现金8,300,796,275.195,417,218,551.922,749,877,070.7812,257,696,998.42
  支付给职工以及为职工支付的现金2,529,408,091.611,880,514,323.341,254,794,780.053,370,452,761.58
  支付的各项税费1,468,892,133.211,047,916,745.19502,050,642.771,967,699,324.78
  支付其他与经营活动有关的现金3,599,018,769.552,428,311,413.721,277,674,178.764,937,178,889.9
  经营活动现金流出小计15,898,115,269.5610,773,961,034.175,784,396,672.3622,533,027,974.68
  经营活动产生的现金流量净额1,647,954,819.97858,391,837.23-336,779,640.632,164,265,059.49
二、投资活动产生的现金流量:
  收回投资收到的现金19,895,042.825,457,778.16373,391.2856,106,178.36
  取得投资收益收到的现金42,605,875.942,263,297.68777,90031,340,550.04
  处置固定资产、无形资产和其他长期资产收回的现金净额6,911,112.156,629,244.215,179,210.4136,183,794
  处置子公司及其他营业单位收到的现金净额156,916,387.4146,300,0002,900,000220,619,202.52
  收到的其他与投资活动有关的现金74,120,422.1257,320,422.12-138,687,500
  投资活动现金流入小计300,448,840.44117,970,742.179,230,501.69482,937,224.92
  购建固定资产、无形资产和其他长期资产支付的现金628,293,200.62380,636,508.28249,050,876.061,020,943,995.37
  投资支付的现金---6,750,000
  取得子公司及其他营业单位支付的现金---53,039,279.92
  支付其他与投资活动有关的现金45,158,691.3345,158,691.33-144,229,056.7
  投资活动现金流出小计673,451,891.95425,795,199.61249,050,876.061,224,962,331.99
  投资活动产生的现金流量净额-373,003,051.51-307,824,457.44-239,820,374.37-742,025,107.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金---18,010,000
  其中:子公司吸收少数股东投资收到的现金---18,010,000
  取得借款收到的现金8,274,673,0005,239,810,0002,257,490,0009,348,149,069.22
  收到其他与筹资活动有关的现金266,603,648.59174,205,255.5577,739,393.43494,776,099.48
  筹资活动现金流入小计8,541,276,648.595,414,015,255.552,335,229,393.439,860,935,168.7
  偿还债务支付的现金8,597,194,705.394,768,818,731.691,913,455,029.429,440,221,160.49
  分配股利、利润或偿付利息支付的现金1,087,422,843.88461,461,009.5111,452,680.241,390,240,847.57
  其中:子公司支付给少数股东的股利、利润85,175,615.9253,353,198.823,164,378.32120,931,806.9
  支付其他与筹资活动有关的现金310,904,141.74278,439,128.22129,147,679.63528,470,522.67
  筹资活动现金流出小计9,995,521,691.015,508,718,869.412,154,055,389.2911,358,932,530.73
  筹资活动产生的现金流量净额-1,454,245,042.42-94,703,613.86181,174,004.14-1,497,997,362.03
四、汇率变动对现金及现金等价物的影响9,555,984.2114,449,373.586,805,021.75-23,866,875.3
五、现金及现金等价物净增加额-169,737,289.75470,313,139.51-388,620,989.11-99,624,284.91
  加:期初现金及现金等价物余额2,890,820,258.262,890,820,258.262,890,820,258.262,990,444,543.17
  期末现金及现金等价物余额2,721,082,968.513,361,133,397.772,502,199,269.152,890,820,258.26
补充资料:
  净利润-1,497,174,002.51-1,778,342,930.44
  资产减值准备-18,073,491.14-393,861,278.28
  固定资产和投资性房地产折旧-386,911,578.97-759,401,492.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-386,911,578.97-759,401,492.1
  无形资产摊销-108,655,363.79-242,492,192.99
  长期待摊费用摊销-6,053,285.79-17,543,227.89
  处置固定资产、无形资产和其他长期资产的损失-351,249.07-4,472,024.18
  固定资产报废损失-533,663.28-11,821,590.41
  公允价值变动损失-1,618,385.31--112,716,765.01
  财务费用-137,045,343.04-336,704,934.23
  投资损失--53,340,903.96--143,838,770.49
  递延所得税--9,586,365.84-658,265.46
  其中:递延所得税资产减少--2,731,439.24--6,631,221.33
    递延所得税负债增加--6,854,926.6-7,289,486.79
  存货的减少-116,540,501.93--459,024.88
  经营性应收项目的减少--600,646,680.02--764,553,123.28
  经营性应付项目的增加--799,518,953.98--679,476,910.52
  其他---13,273,361.22
  现金的期末余额-3,361,133,397.77-2,890,820,258.26
  减:现金的期初余额-2,890,820,258.26-2,990,444,543.17
  现金及现金等价物的净增加额-470,313,139.51--99,624,284.91
公告日期2025-10-302025-08-282025-04-292025-04-29
审计意见(境内)带强调事项段的无保留意见
TOP↑